JUNIPER PHARMACEUTICALS INC's ticker is JNP and the CUSIP is 48203L107. A total of 54 filers reported holding JUNIPER PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $201,000 | -19.9% | 36,210 | +1.1% | 0.01% | -21.4% |
| Q2 2016 | $251,000 | +5.0% | 35,806 | -0.8% | 0.01% | 0.0% |
| Q1 2016 | $239,000 | -36.8% | 36,094 | -1.5% | 0.01% | -36.4% |
| Q4 2015 | $378,000 | -9.8% | 36,652 | +3.0% | 0.02% | -18.5% |
| Q3 2015 | $419,000 | +22.9% | 35,599 | -4.4% | 0.03% | +35.0% |
| Q2 2015 | $341,000 | – | 37,237 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 328,132 | $3,380,000 | 1.26% |
| Krensavage Asset Management, LLC | 288,326 | $2,970,000 | 0.95% |
| EAM Investors, LLC | 146,475 | $1,509,000 | 0.20% |
| ALGERT GLOBAL LLC | 37,017 | $381,000 | 0.18% |
| PERRITT CAPITAL MANAGEMENT INC | 73,000 | $752,000 | 0.16% |
| GSA CAPITAL PARTNERS LLP | 174,064 | $1,793,000 | 0.09% |
| Bellevue Asset Management AG | 50,000 | $515,000 | 0.08% |
| Spark Investment Management LLC | 45,800 | $471,000 | 0.06% |
| CADENCE CAPITAL MANAGEMENT LLC | 82,392 | $849,000 | 0.06% |
| TFS CAPITAL LLC | 34,611 | $356,000 | 0.04% |